SigTuple
Bengaluru, India· Est.
AI‑powered diagnostics platform that automates image‑based medical testing for faster, accurate results.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $40M
AI Company Overview
AI‑powered diagnostics platform that automates image‑based medical testing for faster, accurate results.
OncologyHematologyOphthalmology
Technology Platform
Proprietary deep‑learning models that analyze microscopy and imaging data to automate diagnostic interpretation across hematology, histopathology, and ophthalmology.
Opportunities
Expanding AI‑driven diagnostics into emerging markets and integrating with telemedicine platforms to capture a larger share of routine laboratory testing.
Risk Factors
Regulatory hurdles, data privacy concerns, and competition from well‑funded global AI diagnostics firms could limit market penetration.
Competitive Landscape
Competes with PathAI, Google DeepMind Health, and IBM Watson Health; differentiates through a focus on low‑cost, high‑throughput solutions tailored for emerging market labs.